Comparison of Resistive Index, Pulsatility Index, and Arterial Waveform at the Site of Hepatic Artery Bifurcation in Patients with and without Nonalcoholic, Non-Diabetic Fatty Liver
Novelty in Biomedicine,
Vol. 13 No. 1 (2025),
20 January 2025
,
Page 34-38
https://doi.org/10.22037/nbm.v13i1.46366
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is common. Noninvasive methods to assess fibrosis stage are limited, and biopsy remains the gold standard. We aimed to compare the Doppler ultrasound indices (resistive index (RI), pulsatility index (PI), and arterial waveform) at the place of division of the hepatic artery in patients with and without nonalcoholic non-diabetic fatty liver.
Materials and Methods: This cross-sectional study involved patients with fatty and normal liver. For this purpose, 50 patients with fatty liver with a grade higher than II and confirmed and 50 patients without signs of fatty infiltration in sonography were examined by standard Doppler sonography from the location of the hepatic artery. The patients' waveform, RI, and PI were investigated based on this. The evaluated indicators were analyzed as the average of three consecutive measurements. Finally, the results obtained in the two groups were compared using SPSS statistical software.
Results: One hundred patients were equally divided into two groups with and without NAFLD. The two groups were similar in age, sex, and body mass index (BMI) (all P-values > 0.05). In the case group, the average RI was 0.5 ± 0.08; in the control group, it was 0.63 ± 0.04 (P-value<0.001). PI was 0.5 ± 0.08 in the case group and 0.63 ± 0.04 in the control group (P-value<0.001). In the case group, 74% of the subjects showed a Tardus parvus wave pattern, while in the control group, 100% had a normal wave pattern (P-value<0.001).
Conclusion: RI, PI, and arterial waveform at the site of division of the hepatic artery can be used to diagnose these patients who need a biopsy. They reduce the liver.
- Nonalcoholic fatty liver
- Ultrasound
- Resistive index
- Pulsatility index
How to Cite
References
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23.
Bhala N, Ibrahim Kamal Jouness R, Bugianesi E. Epidemiology and natural history of patients with NAFLD. Current pharmaceutical design. 2013;19(29):5169-76.
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. Journal of clinical gastroenterology. 2006;40:S5-S10.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592-609.
Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846-54.
McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59(9):1265-9.
Arora A, Sharma P. Non-invasive diagnosis of fibrosis in non-alcoholic fatty liver disease. Journal of clinical and experimental hepatology. 2012;2(2):145-55.
Mohammadi A, Ghasemi-rad M, Zahedi H, Toldi G, Alinia T. Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. Medical ultrasonography. 2011;13(3):200-6.
Mohammadinia AR, Bakhtavar K, Ebrahimi‐Daryani N, et al. Correlation of hepatic vein Doppler waveform and hepatic artery resistance index with the severity of nonalcoholic fatty liver disease. Journal of Clinical Ultrasound. 2010;38(7):346-52.
Baikpour M, Ozturk A, Dhyani M, et al. Portal venous pulsatility index: a novel biomarker for diagnosis of high-risk nonalcoholic fatty liver disease. American Journal of Roentgenology. 2020;214(4):786-91.
Soyebi KO, Agboola AS, Oyeleke GK. Diagnostic Value of Ultrasonographic Portal Venous Index in the Assessment of Liver Fibrosis in Chronic Viral Hepatitis in Lagos, Nigeria. Journal of Radiation Medicine in the Tropics. 2021;2(2):72-8.
Solhjoo E, Mansour-Ghanaei F, Moulaei-Langorudi R, Joukar F. Comparison of portal vein doppler indices and hepatic vein doppler waveform in patients with nonalcoholic fatty liver disease with healthy control. Hepatitis Monthly. 2011;11(9):740.
Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD/NASH. Journal of gastroenterology and hepatology. 2013;28:64-70.
Patel PC, Fiet JO. Enhancing the internal validity of entrepreneurship experiments by assessing treatment effects at multiple levels across multiple trials. Journal of Economic Behavior & Organization. 2010;76(1):127-40.
Yu X-y, Zhao Y, Song X-x, Song Z-y. Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population. Journal of Zhejiang University. Science. B. 2014;15(10):879.
Norouzi H, Movahedian H. Effects of Various Stages of NonAlcoholic Fatty Liver Disease Associated with Elevated Liver Enzyme (AST/ALT) Upon Hemodynamic Portal Vein. medical journal of mashhad university of medical sciences. 2015;58(4):185-90.
Tana C, Tana M, Rossi S, Silingardi M, Schiavone C. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. Journal of ultrasound. 2016;19:183-9.
Lu S, Archard R, Mcleod L, et al. Portal Venous Pulsatility Index as a predictor of fibrosis in patients with non‐alcoholic fatty liver disease. Australasian Journal of Ultrasound in Medicine. 2022;25(1):36-41.
- Abstract Viewed: 55 times
- pdf Downloaded: 35 times